BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 33059828)

  • 21. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.
    Pibarot P; Weissman NJ; Stewart WJ; Hahn RT; Lindman BR; McAndrew T; Kodali SK; Mack MJ; Thourani VH; Miller DC; Svensson LG; Herrmann HC; Smith CR; Rodés-Cabau J; Webb J; Lim S; Xu K; Hueter I; Douglas PS; Leon MB
    J Am Coll Cardiol; 2014 Sep; 64(13):1323-34. PubMed ID: 25257633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
    Ong G; Pibarot P; Redfors B; Weissman NJ; Jaber WA; Makkar RR; Lerakis S; Gopal D; Khalique O; Kodali SK; Thourani VH; Anwaruddin S; McAndrew T; Zhang Y; Alu MC; Douglas PS; Hahn RT
    J Am Coll Cardiol; 2020 Dec; 76(25):2940-2951. PubMed ID: 33334422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR.
    Chhatriwalla AK; Allen KB; Depta JP; Rodriguez E; Thourani VH; Whisenant BK; Zahr F; Bapat V; Garcia S
    JACC Cardiovasc Interv; 2023 Mar; 16(5):530-539. PubMed ID: 36922038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials.
    Summers MR; Leon MB; Smith CR; Kodali SK; Thourani VH; Herrmann HC; Makkar RR; Pibarot P; Webb JG; Leipsic J; Alu MC; Crowley A; Hahn RT; Kapadia SR; Tuzcu EM; Svensson L; Cremer PC; Jaber WA
    Circulation; 2019 Dec; 140(24):1984-1994. PubMed ID: 31690104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.
    Galper BZ; Chinnakondepalli KM; Wang K; Magnuson EA; Lu M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Williams M; Webb J; Smith CR; Mack MJ; Leon MB; Cohen DJ;
    Circulation; 2023 May; 147(21):1594-1605. PubMed ID: 37154049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Valve Durability and Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Symptomatic Aortic Stenosis and Less-Than-High-Risk for Surgery.
    Tzamalis P; Alataki S; Bramlage P; Schmitt C; Schymik G
    Am J Cardiol; 2020 Apr; 125(8):1202-1208. PubMed ID: 32085868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.
    Del Trigo M; Dahou A; Webb JG; Dvir D; Puri R; Abdul-Jawad Altisent O; Campelo-Parada F; Thompson C; Leipsic J; Stub D; DeLarochellière R; Paradis JM; Dumont E; Doyle D; Mohammadi S; Pasian S; Côté M; Pibarot P; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2016 May; 69(5):501-8. PubMed ID: 26739827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Kapadia SR; Huded CP; Kodali SK; Svensson LG; Tuzcu EM; Baron SJ; Cohen DJ; Miller DC; Thourani VH; Herrmann HC; Mack MJ; Szerlip M; Makkar RR; Webb JG; Smith CR; Rajeswaran J; Blackstone EH; Leon MB;
    J Am Coll Cardiol; 2018 Nov; 72(20):2415-2426. PubMed ID: 30442284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry.
    Ternacle J; Pibarot P; Herrmann HC; Kodali S; Leipsic J; Blanke P; Jaber W; Mack MJ; Clavel MA; Salaun E; Guzzetti E; Annabi MS; Bernier M; Beaudoin J; Khalique OK; Weissman NJ; Douglas P; Bax J; Dahou A; Xu K; Alu M; Rogers E; Leon M; Thourani VH; Abbas AE; Hahn RT
    JACC Cardiovasc Interv; 2021 Jul; 14(13):1466-1477. PubMed ID: 34238557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valve-in-Valve Transcatheter Aortic Valve Replacement and Bioprosthetic Valve Fracture Comparing Different Transcatheter Heart Valve Designs: An Ex Vivo Bench Study.
    Sathananthan J; Sellers S; Barlow AM; Stanová V; Fraser R; Toggweiler S; Allen KB; Chhatriwalla A; Murdoch DJ; Hensey M; Lau K; Alkhodair A; Dvir D; Asgar AW; Cheung A; Blanke P; Ye J; Rieu R; Pibarot P; Wood D; Leipsic J; Webb JG
    JACC Cardiovasc Interv; 2019 Jan; 12(1):65-75. PubMed ID: 30621980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve.
    Pibarot P; Hahn RT; Weissman NJ; Arsenault M; Beaudoin J; Bernier M; Dahou A; Khalique OK; Asch FM; Toubal O; Leipsic J; Blanke P; Zhang F; Parvataneni R; Alu M; Herrmann H; Makkar R; Mack M; Smalling R; Leon M; Thourani VH; Kodali S
    JAMA Cardiol; 2017 Nov; 2(11):1208-1216. PubMed ID: 28973091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Sinha S; Khan A; Qureshi AM; Suh W; Laks H; Aboulhosn J; Biniwale R; Adachi I; Fernando A; Levi D
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):253-261. PubMed ID: 31609055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.
    Eltchaninoff H; Durand E; Avinée G; Tron C; Litzler PY; Bauer F; Dacher JN; Werhlin C; Bouhzam N; Bettinger N; Candolfi P; Cribier A
    EuroIntervention; 2018 Jun; 14(3):e264-e271. PubMed ID: 29599103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.
    Leon MB; Mack MJ; Hahn RT; Thourani VH; Makkar R; Kodali SK; Alu MC; Madhavan MV; Chau KH; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Blanke P; Leipsic JA; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Herrmann HC; Szeto WY; Genereux P; Pershad A; Lu M; Webb JG; Smith CR; Pibarot P;
    J Am Coll Cardiol; 2021 Mar; 77(9):1149-1161. PubMed ID: 33663731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.